3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Transmission: new trials by email Literature Review of Transmission trials Research Report on Transmission
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement BCG, Placebo - COVID-19, Therapeutic Vaccine | Phase 4 | Completed | University of Campinas, Brazil | 400 | 2020-10-01 | 2023-11-30 |
| Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts Hydroxychloroquine - Covid19, Hydroxychloroquine | Phase 4 | Completed | Bryn Mawr Hospital | 54 | 2020-05-27 | 2020-12-03 |
| Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B Telbivudine, Lamivudine - Chronic Hepatitis B, Late Pregnancy | Phase 4 | Completed | Beijing YouAn Hospital | 700 | 2009-01-01 | 2013-07-30 |
COVID-19 (2) · Coronavirus Infections (1) · Hepatitis B, Chronic (1)
Infections (3) · Virus Diseases (3) · Coronaviridae Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Coronavirus Infections (1) · DNA Virus Infections (1)
BCG Vaccine (1) · Hydroxychloroquine (1) · Lamivudine (1) · Telbivudine (1) · lipoarabinomannan (1)
Beijing YouAn Hospital (1) · Bryn Mawr Hospital (1) · University of Campinas, Brazil (1)
Brazil (1) · China (1) · United States (1)
Calvin Pan, MD (1) · Hua Zhang, MD (1) · Leonardo O Reis, MD, PhD (1)
PMID 25187919, PMID 34037911, PMID 34493311, PMID 35599154, PMID 35738969, PMID 37743116